|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-3-19
|
|
pubmed:abstractText |
Previous trials have suggested a quality-of-life (QOL) improvement for anemic cancer patients treated with erythropoietin, but few used QOL as the primary outcome. We designed a trial to investigate the effects of epoetin alfa therapy on the QOL of anemic patients with advanced non-small-cell carcinoma of the lung (NSCLC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:GagnonBrunoB,
pubmed-author:JulianJim AJA,
pubmed-author:LevineMark NMN,
pubmed-author:MulroyLiamL,
pubmed-author:OkawaraGord SGS,
pubmed-author:PritchardKathleen IKI,
pubmed-author:RoaWilsonW,
pubmed-author:RudinskasLeonaL,
pubmed-author:SmithColumnC,
pubmed-author:SzechtmanBarbaraB,
pubmed-author:UngYee CYC,
pubmed-author:WhelanTimothy JTJ,
pubmed-author:WrightJames RJR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1027-32
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17312332-Adult,
pubmed-meshheading:17312332-Aged,
pubmed-meshheading:17312332-Aged, 80 and over,
pubmed-meshheading:17312332-Anemia,
pubmed-meshheading:17312332-Canada,
pubmed-meshheading:17312332-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17312332-Double-Blind Method,
pubmed-meshheading:17312332-Erythropoietin,
pubmed-meshheading:17312332-Female,
pubmed-meshheading:17312332-Hematinics,
pubmed-meshheading:17312332-Hemoglobins,
pubmed-meshheading:17312332-Humans,
pubmed-meshheading:17312332-Kaplan-Meier Estimate,
pubmed-meshheading:17312332-Lung Neoplasms,
pubmed-meshheading:17312332-Male,
pubmed-meshheading:17312332-Middle Aged,
pubmed-meshheading:17312332-Neoplasm Staging,
pubmed-meshheading:17312332-Proportional Hazards Models,
pubmed-meshheading:17312332-Quality of Life,
pubmed-meshheading:17312332-Recombinant Proteins,
pubmed-meshheading:17312332-Thrombosis,
pubmed-meshheading:17312332-Time Factors,
pubmed-meshheading:17312332-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
|
|
pubmed:affiliation |
Juravinski Cancer Center at Hamilton Health Sciences, Hamilton, Ontario, Canada. jim.wright@hrcc.on.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
